Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XBI vs. FBDIX: which is better?

Bottom line

XBI vs FBDIX: the short answer

XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.

XBI is cheaper at 0.35% vs 1.01% — a difference of $66 a year per $10,000 invested.

Over five years, FBDIX returned +5.0% a year vs −2.7% for XBI.

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

XBI vs FBDIX side by side

XBIFBDIX
TypeETFMutual fund
Fund familySPDR (State Street)Franklin Templeton
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%1.01%
Annual cost per $10k$35$101
10-yr cost on $10k (prospectus)$443$1,728
Max front loadNone5.5%
12b-1 fee0%0.25%
1-yr return+35.8%+43.9%
5-yr return (annualized)−2.7%+5.0%
10-yr return (annualized)+5.8%+6.4%
Best quarter+44.4%+29.5%
Worst quarter−26.2%−24.5%
Net assets (fund)$10.7B$1.2B
Number of holdings161126
Portfolio turnover71%38%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXBIFBDIXDifference
2025+35.8%+52.3%−16.5%
2024+1.1%+4.0%−2.9%
2023+7.5%+18.4%−10.9%
2022−25.8%−12.7%−13.1%
2021−20.5%−17.7%−2.8%
2020+48.2%+29.9%+18.3%
2019+32.2%+34.8%−2.6%
2018−14.9%−15.7%+0.8%
2017+43.7%+18.8%+24.9%
2016−15.4%−17.2%+1.7%

Source: Fund prospectus bar charts

Holdings overlap

6 of XBI's top 25 holdings also appear in FBDIX's top 25.

Shared top holdings
HoldingXBIFBDIX
Oruka Therapeutics Inc1.38%1.86%
Praxis Precision Medicines Inc1.29%1.91%
Revolution Medicines Inc1.20%3.01%
Dianthus Therapeutics Inc1.18%2.32%
Cytokinetics Inc1.18%1.24%
Mirum Pharmaceuticals Inc1.16%1.98%

Source: SEC Form N-PORT

XBI top 10

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Oruka Therapeutics Inc — 1.38%
  6. Kymera Therapeutics Inc — 1.36%
  7. Viking Therapeutics Inc — 1.30%
  8. Praxis Precision Medicines Inc — 1.29%
  9. Erasca Inc — 1.27%
  10. Revolution Medicines Inc — 1.20%

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

FAQ

What is the difference between XBI and FBDIX?
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 18% of their top holdings (by weight) are shared. XBI is cheaper at 0.35% vs 1.01% — a difference of $66 a year per $10,000 invested.
Which is cheaper, XBI or FBDIX?
XBI has the lower expense ratio (0.35%).
Should I own both XBI and FBDIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.